In December 2024, Western Europe’s PV selling rate continued its upward trend, reaching 13.1 million units/year. Year-on-year ...

Led by technology companies, the total market capitalisation of top 50 firms in the Asia-Pacific (APAC) region surged to $8.1 ...

From once-weekly subcutaneously injectable medicines agonizing the glucagon-like peptide 1 receptor (GLP-1R), longer-acting candidates allowing once-monthly administration may become the next ...

While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

According to preliminary estimates released by GlobalData, US Light Vehicle sales grew by 2.4% year-on-year in December, to 1.51 million units.

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Consumer hesitation around taste remains a main challenge to successfully marketing alternative food and drink products, says GlobalData.

Based on the data, China’s domestic market saw its second consecutive month of acceleration in November.

Novartis’ Zolgensma, an IV formulation, was FDA-approved in 2019 for patients under two with SMA. However, the new IT ...

The US DoD listed more than 50 companies with a domestic presence as "military companies" advancing China's forces through an MCF strategy.